rotavirus
rv
import
enter
pathogen
newborn
human
anim
caus
diarrhea
rare
case
death
especi
young
individu
rotaviru
vaccin
present
use
modifi
live
vaccin
lack
complet
biolog
safeti
previou
work
laboratori
suggest
vaccin
base
situ
produc
noninfecti
rotaviruslik
particl
rvlp
effici
entir
safe
howev
use
either
vaccin
activ
mucos
immun
induc
protect
immun
newborn
due
immatur
immun
system
therefor
hypothes
offspr
vaccin
dam
passiv
immun
either
transfer
matern
antibodi
pregnanc
take
antibodi
milk
use
codon
optim
polycistron
gene
express
cassett
packag
herpesviru
particl
simultan
express
rv
capsid
gene
led
intracellular
format
rvlp
variou
cell
line
vaccin
dam
develop
strong
rv
specif
igg
antibodi
respons
determin
sera
milk
mother
pup
moreov
sera
pup
nurs
vaccin
dam
also
rv
specif
antibodi
suggest
lactogen
transfer
antibodi
although
full
protect
pup
achiev
mous
model
observ
import
develop
improv
vaccin
rv
human
well
variou
anim
speci
rotaviru
rv
enter
pathogen
human
vertebr
symptom
rv
infect
includ
gastroenter
lead
dehydr
diarrhea
death
case
review
see
estim
children
age
five
die
diarrhea
importantli
fatal
diarrhea
case
associ
rv
although
licens
rv
vaccin
avail
protect
effect
sever
rv
induc
diarrhea
found
extrem
region
specif
good
effici
develop
region
contrast
region
subsaharan
africa
protect
global
approv
vaccin
includ
either
live
attenu
rotarix
glaxosmithklin
inc
rixensart
belgium
reassort
rv
strain
rotateq
merck
co
inc
whitehous
station
nj
usa
henc
vaccin
base
replic
viral
strain
thu
safe
natur
case
report
describ
rv
transmiss
rotateq
vaccin
child
unvaccin
sibl
vaccin
associ
infect
result
gastroenter
requir
emerg
care
transmit
rv
strain
reassort
vaccinederiv
strain
reassort
may
result
recoveri
virul
addit
rv
vaccin
found
associ
slightli
increas
risk
intussuscept
primari
vaccin
therefor
necessari
develop
effici
particular
safer
vaccin
present
find
altern
vaccin
approach
ultim
aim
protect
children
rv
infectionassoci
symptom
earli
time
life
viruslikeparticl
vlp
compos
one
sever
viral
capsid
protein
selfassembl
spatial
conform
resembl
structur
origin
viru
viruslikeparticl
compris
high
densiti
epitop
surfac
recogn
antigen
present
cell
apc
therebi
stimul
humor
cellular
immun
respons
similar
pathway
complet
pathogen
viru
viruslikeparticl
contain
genet
materi
thu
replic
therefor
consid
safe
vaccin
base
purifi
vlp
exampl
gardasil
merck
co
inc
whitehous
station
nj
usa
cervarix
glaxosmithklin
inc
brentford
uk
human
papilloma
viru
hpv
immun
recombivax
hb
hepat
b
viru
hbv
merck
co
inc
whitehous
station
nj
usa
market
matur
infecti
rv
particl
nonenvelop
triplelay
capsid
compos
structur
protein
form
inner
shell
assembl
middl
layer
third
outer
layer
form
netlik
structur
adher
attach
host
cell
capsid
also
contain
spike
protrud
pore
attach
layer
produc
vlp
rv
mani
express
vector
exist
sever
vaccin
candid
proven
effect
rv
induc
diarrhea
viru
shed
small
anim
model
triplelay
vlp
contain
doublelay
vlp
consist
exampl
approach
moreov
subunit
vaccin
produc
eukaryot
cell
express
solubl
protein
escherichia
coli
assembl
vlp
show
protect
rv
induc
diseas
howev
assembl
rv
structur
protein
rotaviru
like
particl
rvlp
requir
simultan
express
sever
recombin
rv
gene
singl
cell
follow
multipl
purif
step
rvlp
challeng
step
product
stabl
massproduc
vaccin
circumv
problem
maintain
eas
applic
safeti
decid
trigger
immun
respons
use
rvlp
produc
within
cell
vaccine
absenc
rv
genom
synthesi
use
herp
simplex
viru
amplicon
vector
deliv
dna
cassett
singl
polycistron
messeng
rna
contain
code
sequenc
three
capsid
protein
separ
intern
ribosom
entri
site
product
rvlp
amplicon
vector
system
high
transgen
capac
kb
safe
transgen
unabl
replic
allow
deliveri
synthet
dna
encod
antigen
interest
system
time
consum
complex
purif
vlp
requir
herp
simplex
viru
amplicon
vector
transduct
trigger
rvlp
product
shown
previou
studi
laboratori
dramat
underrepres
compar
structur
vaccinolog
approach
involv
engin
immunogen
use
combin
structur
biolog
immunolog
idea
protect
antigen
optim
simplifi
inclus
vaccin
formul
enhanc
efficaci
stabil
deliveri
obtain
stronger
immunogen
henc
broader
protect
import
goal
structur
vaccinolog
conform
stabil
antigen
base
nativ
threedimension
structur
induc
efficaci
immun
respons
base
principl
aim
increas
amount
vlpgener
immun
protein
synthes
situ
chose
alter
sequenc
viral
gene
amplicon
vector
optim
amino
acid
sequenc
codon
usag
human
cell
protect
newborn
human
mice
variou
pathogen
support
placent
transfer
antibodi
mother
child
addit
birth
via
lactogen
rout
notabl
number
placent
layer
mother
fetus
differ
variou
mammal
affect
inhibit
abil
transfer
antibodi
pregnanc
mammal
cluster
three
group
human
belong
group
due
singl
layer
placenta
type
major
amount
immunoglobulin
transfer
fetu
prior
parturit
group
mice
dog
exampl
immunoglobulin
transfer
placent
lactogen
pathway
effici
differ
isotyp
antibodi
transfer
milk
differ
individu
speci
although
awar
differ
interest
observ
gener
potenc
vaccin
type
mous
model
thu
studi
kinet
antirv
antibodi
product
sera
mice
well
milk
moreov
test
prepartum
antibodi
transfer
compar
postpartum
transfer
milk
final
also
test
protect
effect
passiv
antibodi
transfer
context
challeng
infect
show
transduct
cell
vitro
amplicon
vector
deliv
dna
cassett
encod
singl
polycistron
messeng
rna
contain
code
sequenc
three
capsid
protein
trigger
synthesi
three
encod
rv
protein
moreov
protein
assembl
rvlp
within
transduc
cell
administ
intramuscularli
rv
protein
encod
amplicon
vector
induc
rv
specif
antibodi
respons
detect
sera
well
milk
vaccin
dam
addit
sera
unvaccin
offspr
nurs
vaccin
anim
although
lactogen
transfer
rv
specif
immunoglobulin
g
igg
pup
vaccin
dam
occur
full
protect
newborn
rv
induc
symptom
achiev
present
experiment
condit
amplicon
vector
use
studi
shown
schemat
figur
sequenc
construct
synthet
transgen
cassett
swa
swa
deriv
human
rv
strain
wa
codonoptim
human
gene
codon
prefer
construct
describ
materi
method
section
amplicon
vector
encod
green
fluoresc
protein
gfp
use
control
vector
synthesi
rv
protein
mediat
synthet
amplicon
vector
swa
swa
confirm
western
blot
analysi
total
cell
lysat
follow
transduct
cell
three
rv
protein
synthes
human
nonhuman
cell
shown
figur
human
hepatocellular
cell
furthermor
tag
detect
use
antibodi
cell
transduc
swa
figur
middl
panel
design
synthet
amplicon
vector
swa
swa
base
vector
rrv
aim
improv
transcriptiontransl
transgen
cassett
codonoptim
human
codon
usag
optim
codon
usag
codon
adapt
index
cai
increas
human
mous
inde
codonoptim
vector
swa
induc
enhanc
protein
synthesi
human
cell
noncodonoptim
vector
rrv
figur
left
panel
effect
observ
murin
hepatoma
cell
line
figur
right
panel
even
though
cai
codon
usag
human
mice
similar
next
subcellular
distribut
differ
rv
structur
protein
vector
transduc
cell
examin
confoc
laser
scan
microscopi
specif
antibodi
figur
signal
detect
punctat
pattern
distribut
throughout
cytoplasm
express
appear
discret
punctat
circular
structur
cytoplasm
detect
cytoplasm
dot
structur
form
aggreg
compar
concanavalin
cona
stain
endoplasm
reticulum
er
membran
local
er
previous
describ
result
demonstr
three
rv
structur
protein
synthes
newli
design
cassett
human
nonhuman
cell
codonoptim
led
increas
quantiti
gener
rv
protein
human
cell
next
subcellular
distribut
differ
rv
structur
protein
vector
transduc
cell
examin
confoc
laser
scan
microscopi
specif
antibodi
figur
signal
detect
punctat
pattern
distribut
throughout
cytoplasm
express
appear
discret
punctat
circular
structur
cytoplasm
detect
cytoplasm
dot
structur
form
aggreg
compar
concanavalin
cona
stain
endoplasm
reticulum
er
membran
local
er
previous
describ
result
demonstr
three
rv
structur
protein
synthes
newli
design
cassett
human
nonhuman
cell
codonoptim
led
increas
quantiti
gener
rv
protein
human
cell
next
step
cell
transduc
swa
ultrathin
section
prepar
transmiss
electron
microscopi
tem
figur
b
structur
detect
resembl
rv
particl
viroplasm
prove
structur
repres
accumul
rv
protein
correl
light
electron
microscopi
done
figur
ultrathin
section
vectortransduc
cell
label
indic
materi
method
section
imag
fluoresc
microscop
result
micrograph
use
map
record
area
electron
microscop
em
figur
show
overlay
fluoresc
em
imag
figur
enlarg
area
interest
record
em
focus
highli
rvantibodyposit
mark
electrondens
region
electrondens
antibodyposit
region
show
regularli
shape
circular
structur
form
aggreg
cluster
resembl
viru
particl
conclud
observ
circular
structur
repres
inde
rvlp
form
cytoplasm
transduc
cell
resembl
viroplasm
found
rvinfect
cell
conclud
observ
circular
structur
repres
inde
rvlp
form
cytoplasm
transduc
cell
resembl
viroplasm
found
rvinfect
cell
cell
harvest
hpt
monolay
pellet
fixat
formaldehyd
embed
lr
white
ultrathin
section
directli
collect
grid
prepar
immun
fluoresc
imag
taken
use
fluoresc
microscop
thereaft
grid
process
electron
microscopi
fluoresc
imag
open
softwar
map
scan
electron
microscop
sem
comput
align
secondari
electron
imag
tileset
imag
record
use
highangl
annular
darkfield
detector
c
overlay
fluoresc
electron
microscop
imag
stitch
tileset
imag
cover
entir
cell
interest
fluoresc
micrograph
dapi
use
stain
nuclei
blue
rv
protein
stain
use
antirv
serum
secondari
antibodi
conjug
alexafluor
green
cell
harvest
hpt
monolay
pellet
fixat
formaldehyd
embed
lr
white
ultrathin
section
directli
collect
grid
prepar
immun
fluoresc
imag
taken
use
fluoresc
microscop
thereaft
grid
process
electron
microscopi
fluoresc
imag
open
softwar
map
scan
electron
microscop
sem
comput
align
secondari
electron
imag
tileset
imag
record
use
highangl
annular
darkfield
detector
c
overlay
fluoresc
electron
microscop
imag
stitch
tileset
imag
cover
entir
cell
interest
fluoresc
micrograph
dapi
use
stain
nuclei
blue
rv
protein
stain
use
antirv
serum
secondari
antibodi
conjug
alexafluor
green
enlarg
area
interest
stitch
tileset
show
highli
rvpositivemark
electrondens
region
mark
c
scale
bar
c
inject
femal
mice
transduc
unit
tu
per
dose
intramuscularli
im
primeboost
regimen
swa
gfp
encod
amplicon
vector
control
five
day
first
immun
male
ad
femal
mate
figur
nineteen
day
prime
immun
dam
boost
blood
milk
sampl
dam
collect
parturit
test
rv
specif
igg
antibodi
use
rv
strain
wa
specif
enzymelink
immunosorb
assay
elisa
rotaviru
specif
igg
antibodi
found
sera
swa
immun
mice
differ
significantli
sera
gfp
immun
control
mice
figur
data
use
gener
plot
well
number
anim
includ
studi
pvalu
provid
appendix
tabl
mice
immun
swa
show
rel
rvspecif
igg
rigg
level
day
postboost
immun
dpb
decreas
rigg
dpb
decreas
rigg
dpb
rel
igg
preimmun
sera
anim
group
close
rigg
valu
anim
swa
group
anim
gfp
group
rigg
level
gfp
vector
immun
control
group
low
entir
durat
experi
dpb
dpb
dpb
indic
rv
specif
antibodi
respons
trigger
upon
swa
vector
immun
rotavirusspecif
igg
milk
swa
immun
mice
parallel
titer
sera
figur
detail
see
appendix
tabl
day
parturit
day
level
milk
swa
immun
anim
found
increas
day
slightli
decreas
rigg
day
parturit
contrast
gfp
immun
anim
show
background
igg
milk
day
day
day
parturit
level
rvspecif
iga
antibodi
milk
sera
sampl
test
sensit
elisa
use
importantli
titer
sera
milk
antibodi
similar
deliveri
first
seven
day
figur
tabl
analyz
isotyp
rv
specif
igg
rais
upon
swa
immun
gfp
control
tabl
swa
immun
dam
show
higher
level
compar
tabl
sera
offspr
compar
ratio
accord
mother
tabl
indic
type
helper
immun
respons
induc
vaccin
next
experi
dam
immun
primeboost
regimen
either
swa
amplicon
control
gfp
amplicon
hank
balanc
salt
solut
hbss
figur
tabl
milk
serum
rigg
level
dam
use
experi
pup
swap
birth
shown
figur
similar
rv
specif
igg
titer
found
termin
sera
pup
swa
immun
dam
sera
pup
nurs
hbss
control
inject
dam
figur
group
b
rv
specif
igg
swa
immun
dam
thu
pass
offspr
nurs
control
pup
lactogen
rout
also
exchang
offspr
swa
immun
dam
offspr
hbss
inject
control
dam
immedi
birth
termin
exsanguin
remain
matern
antibodi
titer
pup
six
day
follow
transfer
control
dam
could
analyz
figur
group
c
antibodi
titer
still
elev
compar
control
figur
group
data
gener
plot
figur
number
includ
anim
experi
shown
tabl
appendix
tabl
appendix
show
pvalu
group
figur
immun
femal
balbc
mice
blood
sampl
collect
anim
five
day
intra
muscular
im
inject
prime
dose
male
ad
mate
booster
immun
blood
sampl
taken
first
set
experi
mice
receiv
booster
immun
day
prime
dose
inject
second
set
experi
day
prime
dose
inject
blood
milk
sampl
taken
regular
basi
start
day
parturit
bd
rotaviru
specif
immunoglobulin
g
igg
serum
b
milk
c
level
immun
mous
dam
determin
enzymelink
immunosorb
assay
elisa
rotavirusspecif
igg
sera
dilut
milk
dilut
either
swa
gfp
amplicon
vector
immun
anim
measur
plot
rel
posit
control
appli
elisa
plate
taken
posit
control
alway
sera
rv
hyperimmun
mous
previou
studi
e
rotavirusspecif
igg
level
pup
sera
determin
elisa
rotavirusspecif
igg
termin
sera
offspr
either
swa
gfp
amplicon
vector
immun
dam
hank
balanc
salt
solut
hbss
inject
control
dam
plot
relat
posit
control
set
group
offspr
born
rais
swa
immun
dam
group
b
offspr
born
hbss
inject
dam
rais
swa
immun
dam
group
c
includ
offspr
born
swa
immun
dam
rais
hbss
inject
control
dam
group
includ
offspr
born
rais
hbssinject
control
anim
group
e
includ
offspr
born
rais
gfp
vector
immun
dam
dam
obtain
booster
dose
day
prime
immun
standard
deviat
group
indic
pvalu
versu
c
e
b
versu
c
e
indic
p
conclud
rv
specif
igg
antibodi
transfer
via
placent
rout
occur
moreov
level
antibodi
maintain
lactogen
rout
immun
dam
substitut
pup
milk
immun
dam
figur
conclus
abl
show
inject
swa
amplicon
vector
rais
rv
specif
immun
respons
detect
igg
sera
well
milk
immun
anim
respons
pass
offspr
via
placent
lactogen
rout
test
vaccineinduc
immun
respons
suckl
mice
suffici
protect
symptom
rv
infect
therefor
challeng
pup
group
either
swap
nonswap
oral
gavag
mous
rvstrain
edim
diarrhea
dose
two
five
day
birth
pup
develop
diarrhea
within
compar
period
incub
time
thu
immun
respons
rais
suffici
protect
suckl
mice
rv
induc
symptom
experiment
set
report
rv
becom
system
leav
intestin
rout
emerg
blood
strain
edim
propag
vitro
viral
load
sera
pup
analyz
use
rv
specif
quantit
realtim
polymeras
chain
reaction
rtqpcr
first
set
experi
show
promis
result
indic
pup
vaccin
dam
lowest
titer
wherea
pup
swap
time
higher
valu
reflect
antibodi
titer
tabl
subsequ
experi
indic
variabl
due
age
pup
time
challeng
thu
possibl
development
stage
immun
matur
weight
pup
limit
sera
collect
due
need
kill
experiment
anim
tabl
conclud
ethic
question
control
variabl
select
multitud
anim
order
standard
immun
includ
control
birth
date
size
litter
bodi
weight
pup
variou
swap
experi
challeng
experi
protect
oral
rv
challeng
suckl
mice
achiev
next
step
analyz
specif
rv
antibodi
sera
vaccin
dam
immun
vector
swa
compris
three
rv
antigen
main
structur
protein
thu
expect
antibodi
three
rv
antigen
immun
anim
test
immun
fluoresc
perform
use
sera
vaccin
mice
appropri
control
figur
gener
antigen
cell
transduc
amplicon
vector
encod
singl
rv
protein
gfp
sera
dam
vaccin
swa
bound
figur
first
row
true
mice
group
sera
dam
vaccin
control
vector
express
gfp
hbss
control
dam
recogn
rv
protein
specif
figur
middl
row
although
minor
unspecif
background
stain
seen
occasion
summari
antibodi
rv
protein
detect
sera
swa
vaccin
dam
amplicon
vector
encod
singl
rv
protein
gfp
sera
dam
vaccin
swa
bound
figur
first
row
true
mice
group
sera
dam
vaccin
control
vector
express
gfp
hbss
control
dam
recogn
rv
protein
specif
figur
middl
row
although
minor
unspecif
background
stain
seen
occasion
summari
antibodi
rv
protein
detect
sera
swa
vaccin
dam
previou
work
show
might
play
key
role
passiv
protect
pup
rvinduc
diarrhea
base
result
immun
fluoresc
analysi
mice
sera
abl
rais
antibodi
blood
swa
vaccin
dam
antibodi
use
amplicon
vector
launch
situ
product
rvlp
provid
advantag
oppos
inject
purifi
vlp
deliveri
vlp
encod
gene
host
cell
result
intracellular
product
antigen
case
expect
format
triplelay
rvlp
therefor
character
natur
antigen
use
vaccin
first
step
rvlp
form
upon
transduct
swa
gene
express
cassett
analyz
use
electron
microscopi
figur
b
second
step
composit
purifi
particl
examin
use
western
blot
analysi
figur
neg
stain
transmiss
electron
microscopi
purifi
cell
lysat
previou
work
show
might
play
key
role
passiv
protect
pup
rvinduc
diarrhea
base
result
immun
fluoresc
analysi
mice
sera
abl
rais
antibodi
blood
swa
vaccin
dam
antibodi
use
amplicon
vector
launch
situ
product
rvlp
provid
advantag
oppos
inject
purifi
vlp
deliveri
vlp
encod
gene
host
cell
result
intracellular
product
antigen
case
expect
format
triplelay
rvlp
therefor
character
natur
antigen
use
vaccin
first
step
rvlp
form
upon
transduct
swa
gene
express
cassett
analyz
use
electron
microscopi
figur
b
second
step
composit
purifi
particl
examin
use
western
blot
analysi
figur
neg
stain
transmiss
electron
microscopi
purifi
cell
lysat
swa
transduc
cell
show
synthes
rv
structur
protein
assembl
rvlp
similar
size
structur
wildtyp
rv
particl
immunogold
label
rvlp
use
rabbit
polyclon
antirv
serum
secondari
antibodi
conjug
gold
particl
confirm
vlp
ident
rvlike
swa
transduc
cell
show
synthes
rv
structur
protein
assembl
rvlp
similar
size
structur
wildtyp
rv
particl
immunogold
label
rvlp
use
rabbit
polyclon
antirv
serum
secondari
antibodi
conjug
gold
particl
confirm
vlp
ident
rvlike
analyz
composit
isol
rvlp
western
blot
analysi
purifi
rvlp
perform
figur
indic
observ
rvlp
consist
predominantli
two
inner
layer
figur
left
panel
wherea
outer
layer
protein
remain
cell
debri
pellet
obtain
purif
rvlp
figur
right
panel
moreov
transmembran
glycoprotein
local
er
seem
local
er
membran
figur
even
though
coexpress
summari
even
though
abundantli
present
transduc
cell
figur
c
hardli
incorpor
isol
rvlp
lead
conclus
system
doublelay
rvlp
preferenti
form
salient
new
find
studi
includ
transduct
cell
amplicon
vector
deliv
dna
cassett
encod
singl
polycistron
messeng
rna
compris
codonoptim
sequenc
three
rv
capsid
protein
trigger
synthesi
three
encod
rv
protein
celltyp
depend
increas
desir
protein
synthesi
due
codonoptim
capsid
protein
code
sequenc
vector
assembl
doublelay
viruslik
particl
synthes
cell
appar
exclud
particl
format
intramuscular
inocul
amplicon
particl
result
product
rvspecif
antibodi
interestingli
antibodi
transfer
mous
progeni
via
uterin
lactogen
pathway
despit
effici
antibodi
transfer
offspr
clinic
protect
diarrhea
upon
experiment
infect
pup
heterolog
mousespecif
rv
achiev
purif
propag
rv
clinic
fecal
specimen
cell
cultur
difficult
adapt
growth
continu
cell
line
high
titer
usual
requir
multipl
round
passag
primari
cell
consequ
result
adapt
usual
includ
alter
amino
acid
sequenc
protein
immunogen
interest
solv
problem
use
synthet
codonoptim
dna
cassett
maintain
origin
rv
strain
wa
dhaka
isol
amino
acid
sequenc
three
major
capsid
protein
particular
strength
approach
threefold
vaccin
easili
adjust
circul
rv
strain
sinc
packag
dna
sequenc
need
modifi
amplicon
vector
high
transgen
capac
kb
ensur
multipl
copi
rv
protein
encod
gene
deliv
therebi
trigger
high
amount
protein
synthesi
vlp
purif
expens
time
consum
omit
vlp
form
situ
rational
structur
vaccinolog
maintain
nativ
threedimension
structur
stabil
conform
antigen
induc
efficaci
immun
respons
other
report
assembl
structur
protein
vlp
might
crucial
protect
rv
infect
viral
structur
assembl
sever
protein
vlp
surfac
mimick
nativ
virion
allow
crucial
overlap
epitop
recogn
antibodi
would
possibl
use
singl
individu
subunit
antigen
adopt
principl
propos
structur
aspect
rvlp
import
rv
specif
gener
protect
antibodi
base
electron
microscop
analysi
rvlp
produc
vitro
highli
analog
nativ
rv
particl
howev
analysi
reveal
cell
cultur
purifi
rvlp
predominantli
compos
exclud
figur
known
literatur
shown
data
intracellular
local
synthet
protein
figur
associ
membran
er
wherea
form
punctat
structur
within
cytoplasm
coloc
er
membran
fulli
understood
triplelay
particl
tlp
form
condit
howev
cost
et
al
abl
purifi
tlp
follow
coinfect
insect
cell
three
differ
baculovirus
ie
one
express
three
capsid
protein
contrast
find
upon
synthesi
mammalian
cell
abundantli
synthes
copurifi
vlp
instead
upon
vlp
purif
remain
pellet
togeth
cellular
debri
even
surprisingli
antibodi
induc
circumst
consequ
might
requir
tlp
format
differ
insect
cell
mammalian
cell
inde
accord
other
coexpress
andor
togeth
three
capsid
protein
may
play
pivot
role
assembl
third
layer
better
understand
rv
assembl
process
need
solv
problem
incorpor
vlp
futur
protect
rv
infect
adult
mice
measur
reduct
fecal
viru
shed
oral
challeng
adult
mous
model
howev
speci
includ
human
mice
rv
infect
adult
usual
asymptomat
caus
diarrhea
similar
human
babi
contrast
adult
human
mice
newborn
mice
develop
sever
diarrhea
upon
rv
infect
particularli
first
day
life
howev
immun
system
newborn
fulli
matur
stage
thu
immun
mother
result
protect
transfer
antibodi
repertoir
offspr
repres
import
altern
also
mimick
mous
model
inde
protect
rv
diarrhea
passiv
matern
transfer
antibodi
report
mous
matern
antibodi
model
use
liverotaviru
vaccin
recombin
adenoviru
express
recombin
protein
express
e
coli
vlp
assembl
insect
cell
capsid
protein
express
e
coli
assembl
vlp
postpurif
wide
accept
bcell
arm
immun
respons
play
major
role
control
rv
infect
observ
report
mous
experi
also
clinic
studi
piglet
children
howev
mechan
antibodi
produc
cell
precis
act
rv
unclear
therefor
extens
discuss
field
import
note
amplicon
vector
induc
type
immun
respons
increas
level
tabl
believ
effect
control
viral
infect
respons
might
indic
system
would
abl
induc
mucos
iga
human
adult
mous
model
fecal
iga
antibodi
main
correl
protect
rv
infect
suggest
specif
antibodi
taken
polymer
ig
receptor
infect
enterocyt
neutral
rv
intracellularli
howev
passiv
transfer
antibodi
newborn
suffici
protect
diarrhea
cost
et
al
demonstr
nasal
immun
mice
purifi
tlp
assembl
insect
cell
compris
trigger
high
milk
serum
antibodi
titer
furthermor
milk
serum
antibodi
associ
protect
suckl
mice
antibodi
play
crucial
role
antigen
includ
approach
shown
three
protein
synthes
transduc
cell
confid
achiev
similar
result
protect
studi
cost
et
al
though
igg
upon
situ
synthesi
viral
protein
instead
immun
purifi
vlp
inde
vaccin
mice
produc
high
anti
rv
igg
antibodi
titer
serum
milk
transfer
antibodi
offspr
howev
unabl
detect
rv
specif
iga
antibodi
vaccin
mice
consequ
clear
protect
diarrhea
achiev
agreement
previou
studi
report
protect
rotaviru
diarrhea
reli
lactogen
transfer
iga
cours
sever
factor
contribut
clinic
protect
rv
includ
close
match
antibodi
target
antigen
amount
isotyp
antibodi
well
locat
act
present
case
transfer
antibodi
immun
mother
suckl
mice
seem
effici
howev
least
three
factor
might
influenc
protect
outcom
neg
way
stringent
stop
criteria
anim
experi
allow
examin
durat
sever
rv
symptom
offspr
differ
experiment
group
antibodi
isotyp
gener
upon
vaccin
predominantli
igg
wherea
iga
suppos
provid
better
level
protect
particularli
gut
hand
one
may
consid
matern
antibodi
recov
gut
consequ
suckl
milk
contain
antibodi
thu
challeng
viru
potenti
protect
antibodi
opportun
meet
react
gut
least
certain
amount
time
therefor
surpris
note
obviou
protect
effect
could
achiev
note
use
heterolog
rvlp
base
human
rv
strain
wa
mice
challeng
heterotyp
rv
murin
strain
edim
thu
might
even
antibodi
rais
protect
observ
poor
crossreact
rais
antibodi
accord
butler
et
al
mammal
cluster
three
group
respect
lactogen
immun
rodent
classifi
group
show
particularli
good
absorpt
igg
gut
drain
gut
function
antibodi
human
classifi
group
absorb
littl
immunoglobulin
gut
leav
antibodi
work
suppos
throughout
rv
infect
pig
classifi
group
show
extens
absorpt
class
immunoglobulin
first
h
afterward
milk
antibodi
known
work
sever
week
particularli
well
porcin
gut
properti
even
enhanc
abil
pig
produc
high
amount
iga
respons
vaccin
conclud
reason
state
present
use
mous
model
may
suboptim
test
rv
vaccin
design
human
use
two
possibl
futur
approach
emerg
consider
vaccin
test
pregnant
women
order
analyz
antibodi
specif
isotyp
serum
well
milk
pig
cattl
also
belong
group
might
vaccin
order
produc
decent
amount
iga
variou
rv
strain
iga
may
find
use
medicin
well
veterinari
medicin
vero
african
green
monkey
kidney
epithelium
cell
hepa
mous
epitheli
hepatocyt
atcc
embryon
african
green
monkey
kidney
atcc
human
liver
hepatocellular
cell
atcc
cell
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
unitsml
penicillin
g
streptomycin
amphotericin
b
cell
also
thermo
fisher
scientif
waltham
usa
murin
wild
type
wt
rv
strain
edim
obtain
harri
greenberg
depart
medicin
microbiolog
immunolog
stanford
univers
school
medicin
stanford
ca
usa
titrat
wt
rv
edim
use
challeng
mice
vaccin
describ
previous
human
rv
strain
wa
obtain
catherin
eichwald
univers
zurich
zurich
switzerland
propag
cell
previous
describ
sequenc
construct
synthet
transgen
cassett
swa
swa
deriv
human
rv
strain
wa
dhaka
isol
codonoptim
human
gene
codon
preferenceverifi
genescript
piscataway
nj
usa
synthes
biomatik
cambridg
ontario
canada
predict
splice
site
remov
codon
adapt
index
calcul
use
european
molecular
biolog
open
softwar
suit
emboss
herp
simplex
viru
amplicon
plasmid
clone
use
gateway
technolog
thermo
fisher
scientif
waltham
usa
attb
flank
synthet
gene
express
cassett
swarv
encod
rv
protein
separ
intern
ribosom
entri
site
ire
either
without
stop
codon
end
gener
biomatik
gateway
bp
recombin
attb
flank
swarv
cassett
attp
contain
donor
vector
led
two
entri
plasmid
contain
swarv
gene
express
cassett
flank
attl
site
either
peswarvstop
without
stop
codon
peswarv
amplicon
plasmid
use
produc
swa
vector
stock
gener
gateway
lr
recombin
attl
site
contain
entri
vector
peswarvstop
attr
site
contain
destin
vector
product
swa
amplicon
vector
stock
peswarv
recombin
destin
vector
amplicon
express
plasmid
contain
transcript
unit
consist
immedi
earli
ie
promot
polyadenyl
signal
well
origin
replic
ori
packagingcleavag
signal
pac
necessari
packag
helper
virusfre
amplicon
particl
amplicon
vector
encod
singl
structur
rv
protein
gener
follow
singl
rv
gene
amplifi
use
synthet
gene
express
cassett
swarv
templat
result
pcr
product
insert
phsv
result
amplicon
plasmid
encod
singl
rv
protein
ire
egfp
identifi
vectortransduc
cell
helper
virusfre
amplicon
vector
stock
prepar
previous
describ
briefli
vero
cell
cotransfect
amplicon
plasmid
dna
bac
dna
plasmid
use
lipofectamin
ltx
plu
reagent
thermo
fisher
scientif
h
cell
scrape
medium
freezethaw
sonic
cell
debri
remov
centrifug
immun
mice
vector
stock
purifi
concentr
centrifug
sucros
cushion
titrat
vero
cell
infect
amplicon
vector
h
stain
immun
fluoresc
use
appropri
antibodi
fluoresc
cell
count
use
invert
fluoresc
microscop
axio
observ
invert
microscop
zeiss
ag
oberkochen
germani
titer
determin
tuml
cell
transduc
moi
indic
amplicon
vector
rvlp
harvest
hpt
describ
previous
briefli
cell
scrape
medium
cell
membran
disrupt
repeat
cycl
thawingfreez
cell
debri
remov
centrifug
g
filtrat
filter
clear
supernat
load
onto
sucros
cushion
concentr
g
h
c
protect
proteas
inhibitor
proteas
inhibitor
cocktail
tablet
complet
mini
ethylenediaminetetraacet
acid
edta
free
tablet
per
ml
roch
diagnost
mannheim
germani
ad
supernat
cell
transduc
indic
amplicon
vector
moi
total
cell
lysat
harvest
hpt
hpt
rvlp
purifi
either
whole
cell
lysat
sucros
purifi
rvlp
see
section
rvlp
purif
separ
sodium
dodecyl
sulfat
sd
polyacrylamid
gel
transfer
nitrocellulos
membran
probe
primari
antibodi
stain
use
antimous
sigmaaldrich
buch
switzerland
antirabbit
southern
biotech
birmingham
al
usa
igg
antibodi
conjug
horseradish
peroxidas
hrp
follow
detect
westernbright
ecl
spray
directli
label
zenon
alexafluor
accord
manufactur
instruct
molecular
probe
thermo
fisher
scientif
mous
monoclon
novu
biolog
cambridg
uk
antimous
alexafluor
molecular
probe
thermo
fisher
scientif
mous
monoclon
antibodi
directli
label
fluorescein
isothiocyan
fitc
molecular
probe
er
stain
use
alexafluor
conjug
lectin
cona
conjug
alexa
fluor
pb
molecular
probe
cell
incub
dapi
pb
roch
basel
switzerland
visual
nuclei
wash
cell
pb
h
coverslip
mount
prolong
gold
molecular
probe
sampl
analyz
use
confoc
laserscan
microscop
leica
microsystem
wetzlar
germani
oil
object
numer
apertur
na
analysi
rv
proteinspecif
antibodi
sera
immun
mice
sera
dilut
detect
stain
secondari
antimous
antibodi
conjug
alexafluor
molecular
probe
pictur
taken
use
fluoresc
microscop
axio
observ
invert
microscop
carl
zeiss
ag
oberkochen
germani
neg
stain
sampl
see
section
rvlp
purif
adsorb
carbonco
parlodion
film
mount
meshinch
copper
grid
electron
microscopi
scienc
em
fort
washington
pa
usa
min
wash
h
stain
phosphotungst
acid
pta
ph
aldrich
steinheim
germani
min
specimen
analyz
transmiss
electron
microscop
philip
eindhoven
netherland
equip
ccd
camera
ultrascan
gatan
pleasanton
ca
usa
acceler
voltag
kv
immun
electron
microscopi
sampl
adsorb
carbonco
parlodion
film
mount
meshinch
copper
grid
em
min
block
pb
contain
bsa
min
incub
polyclon
rabbit
antirv
serum
strain
rf
provid
didier
poncet
cnrsinra
gifsuryvett
franc
dilut
h
wash
sever
time
incub
goat
antirabbit
igg
coupl
nm
colloid
gold
particl
jackson
immunoresearch
west
grove
pa
usa
wash
sever
time
pb
h
stain
pta
ph
aldrich
min
specimen
analyz
transmiss
electron
microscop
philip
equip
ccd
camera
ultrascan
gatan
acceler
voltag
kev
cell
transduc
moi
amplicon
vector
swa
h
cell
scrape
medium
resuspend
glutaraldehyd
ga
centrifug
min
g
pellet
embed
epon
accord
standard
protocol
previous
describ
briefli
cell
pellet
fix
ga
postfix
osmium
tetroxid
embed
epoxi
resin
epon
cell
pellet
dehydr
seri
solvent
final
ultrathin
section
stain
uranyl
acet
lead
citrat
coat
carbon
specimen
analyz
transmiss
electron
microscop
philip
equip
ccd
camera
oriu
gatan
acceler
voltag
kev
cell
transduc
moi
amplicon
vector
swa
hpt
cell
scrape
medium
centrifug
min
g
result
cell
pellet
fix
formaldehyd
nak
phosphat
buffer
h
thereaft
pellet
dehydr
ascend
ethanol
seri
start
follow
three
time
absolut
ethanol
min
next
pellet
incub
c
h
mix
lr
whiteethanol
follow
infiltr
lr
white
em
alon
h
final
chang
lr
white
follow
overnight
incub
c
embed
lr
white
done
gelatin
capsul
c
h
oven
ultrathin
section
cut
collect
carbonco
formvar
film
mount
singl
slot
copper
grid
mm
em
describ
ultrathin
section
transduc
cell
embed
lr
white
incub
min
mm
glycin
block
min
block
buffer
gelatin
cold
water
fish
skin
em
hatfield
pa
usa
follow
min
incub
acetyl
bsa
bsac
aurion
wageningen
netherland
ph
room
temperatur
rt
incub
done
overnight
polyclon
goat
antirv
serum
obtain
catherin
eichwald
univers
zurich
zurich
switzerland
dilut
bsac
c
wash
five
time
bsac
section
incub
secondari
antigoat
antibodi
conjug
alexa
fluor
molecular
probe
dilut
bsac
h
rt
wash
time
bsac
h
section
stain
dapi
mgml
min
follow
wash
pb
stain
section
sandwich
microscop
slide
coverslip
pb
seal
nail
polish
fluoresc
microscop
axio
observ
invert
microscop
whole
grid
imag
bright
field
fluoresc
sever
imag
taken
oil
na
object
imag
serv
map
use
find
area
scan
electron
microscop
sem
grid
recov
fluoresc
microscop
set
process
electron
microscopi
ultrathin
section
stain
uranyl
acet
lead
citrat
final
grid
load
scan
transmiss
electron
microscop
stem
holder
sem
helio
nanolab
fei
compani
eindhoven
netherland
imag
taken
fluoresc
microscop
open
sem
comput
use
map
softwar
fei
compani
eindhoven
netherland
special
design
softwar
correl
light
electron
microscopi
read
type
imag
obtain
type
light
microscop
electron
micrograph
record
use
everhartthorney
secondari
electron
detector
align
light
electron
micrograph
done
use
map
softwar
use
two
auspici
point
grid
imag
tile
tileset
drawn
area
interest
indic
fluoresc
imag
tile
size
determin
imag
condit
overlap
imag
condit
kev
na
mm
work
distanc
pixel
per
frame
horizont
field
view
pixel
size
dwell
time
use
stem
iii
detector
fei
compani
highangl
annulardark
field
mode
use
threepoint
focu
regim
three
point
close
area
interest
section
focus
higher
magnif
bright
contrast
adjust
magnif
imag
condit
use
record
imag
final
tile
stitch
softwar
export
tiff
file
circumv
disturb
effect
eg
bleach
occur
overlap
zone
stitch
whole
area
interest
preirradi
high
current
na
larg
frame
size
pixel
short
dwell
time
ns
min
anim
procedur
conduct
accord
regul
swiss
feder
committe
anim
experiment
veterinari
offic
canton
zurich
approv
number
sixtoeightweekold
femal
balbc
mice
im
inocul
day
first
set
experi
day
postprim
second
set
experi
day
postprim
either
indic
amplicon
vector
tu
per
anim
per
dose
hbss
five
day
prime
immun
mice
mate
ad
one
male
two
femal
per
cage
sinc
multipl
blood
sampl
done
regularli
period
two
week
small
blood
sampl
taken
sampl
via
tail
vein
punctuat
collect
use
microcap
capillari
tube
sigmaaldrich
mice
milk
describ
previous
briefli
dam
separ
offspr
h
anesthet
oxytocin
iuml
inject
subcutan
sc
milk
flow
stimul
manual
collect
use
microcap
capillari
tube
serum
milk
igg
analyz
indirect
elisa
describ
previous
briefli
elisa
plate
coat
sucros
concentr
wt
rv
strain
wa
dilut
carbon
buffer
wash
pbstween
phosphat
buffer
salin
tween
incub
sampl
serum
sampl
dilut
milk
sampl
applic
wash
pbstween
well
incub
hrpconjug
goat
antimous
igg
antibodi
pierc
biotechnolog
rockford
il
dilut
analyz
use
peroxidas
substrat
tmb
substrat
solut
thermo
scientif
waltham
reaction
stop
h
optic
densiti
measur
elisa
micropl
reader
order
compar
valu
differ
elisa
plate
serum
pool
rv
hyper
immun
mice
previou
studi
use
normal
valu
take
hyper
immun
sera
evalu
igg
isotyp
standard
biotinyl
isotypespecif
monoclon
antibodi
biolegend
san
diego
ca
usa
detect
hrpconjug
streptavidin
biolegend
san
diego
ca
usa
use
standard
monoclon
immunoglobulin
first
coat
ident
concentr
directli
elisa
plate
antigen
follow
variou
dilut
detect
system
appropri
concentr
antibodi
given
select
serum
sampl
dam
pup
dilut
reanalyz
antigen
coat
igg
isotyp
detect
appropri
standard
detect
system
rotaviru
challeng
suckl
mice
group
perform
oral
gavag
viruscontain
solut
strain
edim
dd
use
feed
needl
pup
monitor
twice
day
rv
symptom
diarrhea
dehydr
well
overal
physic
appear
consid
sick
yellow
liquid
stool
appear
upon
gentl
abdomin
palpat
quantit
realtim
polymeras
chain
reaction
rtqpcr
perform
directli
serum
sampl
serum
sampl
dilut
pb
heat
min
c
cool
immedi
wet
ice
min
use
directli
rtqpcr
reaction
pathid
multiplex
onestep
rtpcr
kit
appli
biosystem
thermo
fisher
scientif
use
amplif
primer
probe
use
vetmax
swine
enter
panel
reagent
appli
biosystem
thermo
fisher
scientif
primer
probe
mix
detect
porcin
rotaviru
abesid
primer
probe
porcin
rotaviru
kit
contain
also
primer
probe
transmiss
gastroenter
coronaviru
tgev
porcin
epidem
diarrhea
viru
pedv
primer
probe
mix
select
sensit
kit
reaction
run
thermal
cycler
touch
biorad
hercul
ca
usa
use
follow
set
revers
transcript
min
c
follow
inactivationiniti
denatur
step
min
c
amplif
perform
cycl
c
c
reaction
done
duplic
calcul
viru
dose
standard
curv
drawn
use
serial
dilut
edim
viru
dilut
neg
mous
serum
treat
describ
triplic
base
result
formula
determin
standard
curv
ln
cq
dd
calcul
sampl
consid
appli
volum
analyz
sampl
dd
ml
determin
dd
ml
enzymelink
immunosorb
assay
measur
analyz
follow
mean
sampl
triplic
calcul
mean
valu
neg
control
plate
subtract
make
valu
plate
compar
alway
posit
control
appli
plate
mean
sampl
triplic
set
relat
mean
posit
control
individu
plate
twoway
anova
weight
mean
perform
calcul
pvalu
sampl
figur
tukey
ad
hoc
test
done
determin
pvalu
group
preprocess
data
normal
calcul
mean
standard
deviat
perform
microsoft
excel
version
twoway
anova
weight
mean
tukey
ad
hoc
test
perform
use
open
sourc
program
rstudio
version
rstudio
inc
boston
usa
graph
gener
rstudio
main
aim
studi
evalu
safe
rvspecif
vaccin
base
nonrepl
amplicon
vector
system
induc
protect
system
antibodi
first
attempt
rv
protein
use
structur
vaccinolog
approach
transduct
rv
protein
encod
amplicon
vector
swa
trigger
synthesi
three
encod
rv
protein
well
intracellular
assembl
rvlp
cell
cultur
distribut
viral
protein
within
cell
resembl
local
protein
wild
type
rv
infect
administ
intramuscularli
rv
protein
encod
amplicon
vector
induc
strong
rv
specif
antibodi
respons
sera
well
milk
vaccin
dam
addit
antibodi
respons
pass
placent
andor
lactogen
rout
unvaccin
offspr
swap
vaccin
dam
expect
lactogen
transfer
rv
specif
igg
protect
suckl
mice
develop
rv
symptom
upon
challeng
indic
control
system
spread
note
requir
target
experi
although
full
protect
oral
rv
challeng
achiev
would
requir
oral
system
vaccin
helpervirusfre
herpesviru
amplicon
vector
use
studi
may
rapidli
adapt
confer
immun
whole
array
differ
rv
meier
perform
experi
mark
suter
kurt
tobler
andrea
laimbach
anita
f
meier
analyz
data
author
contribut
reagentsmaterialsanalysi
tool
mark
suter
mathia
ackermann
andrea
laimbach
anita
f
meier
wrote
paper
author
declar
conflict
interest
figur
well
number
anim
includ
studi
pvalu
figur
well
number
anim
includ
studi
pvalu
shown
tabl
tabl
tabl
show
pvalu
indic
group
data
use
figur
data
display
tabl
